Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

IOS FELLOWS & CAREER PROFESSIONALS KEYNOTE DINNER REVIEW OF ASCO® 2023IOS Thursday, August 24, 2023 5:30 pm – 8:30 pm cdt SCAN HERE OR VISIT HTTPS://BIT.LY/IOS-FELLOWS FOR COMPLIMENTARY REGISTRATION! Join us the evening before the IOS 2023 Review of ASCO® for the IOS Fellows & Career Professionals Keynote Dinner. This complimentary event is crafted for fellows and seasoned experts …
Learn how the creation of the first advanced practice radiation therapist (APRT) role in the United States established a new model of inpatient care, elevating the radiation therapy skill set and allowing for intervention at key points along the radiation oncology care pathway.
By implementing e-consults for patients experiencing endocrine immune-related adverse events, Duke Cancer Institute improved patient access and reduced healthcare utilization.
ACCC is working with multidisciplinary care teams to assess the impact of SDOH on equitable access to cancer care and clinical trials among minority populations.
In this episode, hear about the fully remote TRACK (Target Rare Cancer Knowledge) clinical trial and its unique approach to providing access to biomarker testing for patients in community care settings by leveraging technology.
July 22, 2023
Best of ASCO®, an Official Annual Meeting Review of the American Society of Clinical Oncology® (ASCO®), is a two-day program designed to provide the latest science and education from the world’s premier oncology event, the ASCO® Annual Meeting. The abstracts selected for presentation and discussion reflect the foremost research and strategies in oncology that will impact clinical practice and patient …
July 20, 2023
In this final webinar, hear from our experts Jordan Karwedsky, Financial Counselor, Green Bay Oncology, Wendi Waugh, BS, RT(R)(T), CMD, CRT, Administrative Director of SOMC Cancer Services & Ambulatory Infusion, Southern Ohio Medical Center, and Dr. Michael R. Gieske, Director of Lung Cancer Screening. Join us as we discuss prior authorization challenges in biomarker testing, importance of providing …
SCOS ONCOLOGY DRUG NEWSLETTER FDA APPROVALS Flotufolastat F 18 injection (Posluma) The FDA has granted approval for the flotufolastat F 18 injection (Posluma; formerly 18F-rhPSMA-7.3) for PET of prostate-specific membrane antigen–positive lesions in patients with prostate cancer with suspected metastasis who are eligible for initial definitive therapy or in those with suspected recurrence …
TxSCO Monthly Update 2023-07-13 July 13, 2023 TxSCO Update Overview: Notable Updates 2 Federal • EOM participants announced • Site neutral payments • 340B Proposed Rule • Appendix • PBM reforms • Biden Administration’s “Persistent Poverty Initiative” to Combat Cancer Inequities • Oncology drug shortages • EOM: additional context State • Special …
TACOS ONCOLOGY DRUG NEWSLETTER FDA APPROVALS Flotufolastat F 18 injection (Posluma) The FDA has granted approval for the flotufolastat F 18 injection (Posluma; formerly 18F-rhPSMA-7.3) for PET of prostate-specific membrane antigen–positive lesions in patients with prostate cancer with suspected metastasis who are eligible for initial definitive therapy or in those with suspected recurrence …
TxSCO ONCOLOGY DRUG NEWSLETTER FDA APPROVALS Flotufolastat F 18 injection (Posluma) The FDA has granted approval for the flotufolastat F 18 injection (Posluma; formerly 18F-rhPSMA-7.3) for PET of prostate-specific membrane antigen–positive lesions in patients with prostate cancer with suspected metastasis who are eligible for initial definitive therapy or in those with suspected recurrence …
NCOA ONCOLOGY DRUG NEWSLETTER FDA APPROVALS Flotufolastat F 18 injection (Posluma) The FDA has granted approval for the flotufolastat F 18 injection (Posluma; formerly 18F-rhPSMA-7.3) for PET of prostate-specific membrane antigen–positive lesions in patients with prostate cancer with suspected metastasis who are eligible for initial definitive therapy or in those with suspected recurrence …
Developing a Health Literacy and Clear Communications e-Course AGENDA 6:45 am Registration Open, Networking Breakfast / Resource Center 7:30 am Welcome & Introductions Susannah P. Friemel, MD President, Iowa Oncology Society 7:45 am Melanoma/HCC Asad Javed, MBBS 8:15 am Breast Cancer Vikas Praveen, MD 8:45 am Multiply Myelomas Christopher Strouse, MD 9:15 am Networking …
In the face of an unprecedented drug shortage, HOPA partnered with ACCC and AVAHO to lead a virtual round table discussing best practices the multidisciplinary cancer care team can use to mitigate its effects.
July 15, 2023
Join the Minnesota Society of Clinical Oncology (MSCO) for this annual event focused on professional education and networking to promote career growth and knowledge exchange. MSCO is pleased to offer this complimentary workshop geared towards early career professionals where there is an opportunity to collaborate with clinicians in all stages of their careers and learn from their career …
July 14, 2023
The Roosevelt Hotel New Orleans, LA This three day national conference is designed for medical oncologists, radiation oncologists, surgical oncologists, advanced registered nurse practitioners (ARNP), physician assistants (PA), oncology nurses, registered pharmacists, pharmacy technicians, and radiation therapists. General practitioners (internal medicine and family medicine) will have the benefit …
July 13, 2023
Join us for a complimentary evening of cocktails and networking at our Meet & Greet Reception, hosted by the Louisiana Oncology Society (LOS). This event will take place on Thursday, July 13th to kick off the New Orleans Summer Cancer Meeting (NOSCM). As a special offer, use promo code LOS50 to enjoy a 50% discount on NOSCM registration (excluding Industry professionals). The reception presents …
CANCER BUZZ speaks with Susan Spinosa, president and patient founder of NTRKers, an organization created to support patients with NTRK fusion-positive cancer, about her care journey and the importance of testing for NTRK gene fusions.
Critical Conversations Q&A Navigating Drug Shortages and Empowering Oncology Pharmacists 1 Critical Conversations: Navigating Drug Shortages and Empowering Oncology Pharmacists Audience Q&A | Published: July 7, 2023 Webinar Participants ______________________________________________________________________ 2 Webinar Recording Available ________________________________________________________________ …
In radiation therapy planning, dose-volume histograms (DVH) are used by health insurers to evaluate medical necessity. A DVH is a graphical representation of dose-volume frequency distribution. In preparing to submit a prior authorization, review the patient’s proposed treatment plan to verify the following physics related treatment options: 1. Are there weekly physics …